The embattled firm has reached deals with both the Centers for Medicare & Medicaid Services and Arizona.
Illumina follows Agilent, Life Technologies, Affymetrix, Siemens, and Luminex in settling lawsuits alleging infringement of US Patent No 7,064,197.
Thermo Fisher Scientific subsidiary Life Technologies will pay Enzo $35 million for infringing on two patents pertaining to labeled nucleotides and nucleic acids.
Affymetrix will pay Enzo $10 million to settle litigation Enzo brought against the company over a method for nucleic acid analysis.
Luminex will pay Enzo Biochem $7.1 million to settle a lawsuit alleging infringement of patents for oligonucleotides and solid supports for fixed nucleic acids.
The deal comes after a California Superior Court found no fraudulent intent on the part of the company.
The companies had been involved in a years-long legal battle over whether Genmark's eSensor Respiratory Virus Panel infringed ViroNovative's human metapneumovirus IP.
The preliminary approval is the penultimate step to bringing to a close a class action lawsuit accusing Celera of making false and misleading statements about its finances.
A few more lawsuits related to Myriad Genetics' hereditary cancer testing patents are now put to bed.
The parties have decided to drop their claims and counterclaims against eachother ending a patent infringement lawsuit on BRCA testing.
Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.
University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.
The Wall Street Journal examines billing codes used by uBiome.
In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.